altheas cannabis oil approved for reimbursement in ireland imugene begins phase 1 trial 252221

Althea’s cannabis oil approved for reimbursement in Ireland, Imugene begins Phase 1 trial

 

Cannabis company Althea Group (ASX:AGH) announced that Althea THC20:CBD1 cannabis oil (50 ml) has been approved for reimbursement in Ireland. Althea THC20:CBD1 will be reimbursed for intractable nausea and vomiting associated with chemotherapy. Controlling chemotherapy-induced nausea and vomiting (CINV) is critical to ensure adherence with chemotherapy, and to reduce morbidity and total healthcare costs. The agreed reimbursement price for Althea THC20:CBD1 (50ml) 

​ Cannabis company Althea Group (ASX:AGH) announced that Althea THC20:CBD1 cannabis oil (50 ml) has been approved for reimbursement in Ireland. Althea THC20:CBD1 will be reimbursed for intractable nausea and vomiting associated with chemotherapy. Controlling chemotherapy-induced nausea and vomiting (CINV) is critical to ensure adherence with chemotherapy, and to reduce morbidity and total healthcare costs. The agreed reimbursement price for Althea THC20:CBD1 (50ml) […] 

Read More 

Cannabis Law Report 

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.